CN102712906B - 分化细胞的新型制备方法 - Google Patents

分化细胞的新型制备方法 Download PDF

Info

Publication number
CN102712906B
CN102712906B CN201080042161.7A CN201080042161A CN102712906B CN 102712906 B CN102712906 B CN 102712906B CN 201080042161 A CN201080042161 A CN 201080042161A CN 102712906 B CN102712906 B CN 102712906B
Authority
CN
China
Prior art keywords
cells
gene
cell
myc
oncogene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201080042161.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN102712906A (zh
Inventor
江藤浩之
高山直也
中村壮
中内启光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tokyo NUC
Original Assignee
University of Tokyo NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tokyo NUC filed Critical University of Tokyo NUC
Priority to CN201510530896.9A priority Critical patent/CN105385659B/zh
Publication of CN102712906A publication Critical patent/CN102712906A/zh
Application granted granted Critical
Publication of CN102712906B publication Critical patent/CN102712906B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/48—Regulators of apoptosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/606—Transcription factors c-Myc
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201080042161.7A 2009-09-15 2010-09-15 分化细胞的新型制备方法 Active CN102712906B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510530896.9A CN105385659B (zh) 2009-09-15 2010-09-15 分化细胞的新型制备方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009-213645 2009-09-15
JP2009213645 2009-09-15
PCT/JP2010/065903 WO2011034073A1 (ja) 2009-09-15 2010-09-15 分化細胞の新規製造法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201510530896.9A Division CN105385659B (zh) 2009-09-15 2010-09-15 分化细胞的新型制备方法

Publications (2)

Publication Number Publication Date
CN102712906A CN102712906A (zh) 2012-10-03
CN102712906B true CN102712906B (zh) 2015-09-30

Family

ID=43758674

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201080042161.7A Active CN102712906B (zh) 2009-09-15 2010-09-15 分化细胞的新型制备方法
CN201510530896.9A Expired - Fee Related CN105385659B (zh) 2009-09-15 2010-09-15 分化细胞的新型制备方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201510530896.9A Expired - Fee Related CN105385659B (zh) 2009-09-15 2010-09-15 分化细胞的新型制备方法

Country Status (13)

Country Link
US (2) US9200254B2 (cg-RX-API-DMAC7.html)
EP (2) EP3159001B1 (cg-RX-API-DMAC7.html)
JP (4) JP5791191B2 (cg-RX-API-DMAC7.html)
KR (2) KR101834687B1 (cg-RX-API-DMAC7.html)
CN (2) CN102712906B (cg-RX-API-DMAC7.html)
AU (1) AU2010296415B2 (cg-RX-API-DMAC7.html)
BR (2) BR112012005710B1 (cg-RX-API-DMAC7.html)
CA (1) CA2774193C (cg-RX-API-DMAC7.html)
DK (2) DK2500418T3 (cg-RX-API-DMAC7.html)
ES (2) ES2664194T3 (cg-RX-API-DMAC7.html)
IN (1) IN2012DN02642A (cg-RX-API-DMAC7.html)
RU (2) RU2661107C1 (cg-RX-API-DMAC7.html)
WO (1) WO2011034073A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5861191B2 (ja) * 2010-09-30 2016-02-16 国立大学法人 熊本大学 ミエロイド系血液細胞の製造方法
JP5824760B2 (ja) 2011-05-13 2015-12-02 国立大学法人 東京大学 多核化巨核球細胞、及び血小板の製造方法
RU2014117642A (ru) 2011-10-03 2015-11-10 Ниссан Кемикал Индастриз, Лтд. Способ получения мегакариоцитов и/или тромбоцитов из плюрипотентных стволовых клеток
GB201210857D0 (en) 2012-06-19 2012-08-01 Cambridge Entpr Ltd Transcription factor mediated programming towards megakaryocytes
WO2014100779A1 (en) 2012-12-21 2014-06-26 Advanced Cell Technology, Inc. Methods ofr production of platelets from pluripotent stem cells and compositions thereof
EP2955223B1 (en) * 2013-02-08 2019-12-18 Kyoto University Production methods for megakaryocytes and platelets
WO2014168255A1 (ja) * 2013-04-12 2014-10-16 国立大学法人京都大学 巨核球の成熟化促進物質
EP2987852A4 (en) 2013-04-17 2016-09-07 Nissan Chemical Ind Ltd MEDIA COMPOSITION AND METHOD FOR THE PRODUCTION OF ERYTHROCYTES THEREWITH
EP3760711A1 (en) * 2013-05-15 2021-01-06 University Of Rochester Human extensively self-renewing erythroblasts (esre)
US10112977B2 (en) 2014-06-23 2018-10-30 Toagosei Co., Ltd. Peptide for inducing multinucleation in cells, and use therefor
KR20180015613A (ko) 2015-03-09 2018-02-13 가부시키가이샤 메가카리온 거핵구를 포함하는 배양물의 제조 방법 및 이를 사용한 혈소판의 제조 방법
CA2982568A1 (en) * 2015-04-14 2016-10-20 Kyoto University Method for producing stem cell clone suitable for inducing differentiation into somatic cells
KR20160129609A (ko) 2015-04-30 2016-11-09 삼성전자주식회사 Ｂｒａｆ 저해제를 포함하는 세포 또는 개체의 노화를 감소시키기 위한 조성물 및 그의 용도
JP6856537B2 (ja) * 2015-11-02 2021-04-07 株式会社メガカリオン 往復動撹拌装置を用いた血小板の製造方法および血小板の製造に用いられる培養容器
WO2017131230A1 (ja) 2016-01-29 2017-08-03 国立大学法人京都大学 血小板産生促進剤及びそれを用いた血小板の製造方法
WO2017131228A1 (ja) 2016-01-29 2017-08-03 国立大学法人京都大学 血小板産生促進剤のスクリーニング方法
JP7297203B2 (ja) 2017-03-06 2023-06-26 国立大学法人京都大学 血小板の製造方法
FR3068366B1 (fr) * 2017-06-30 2023-11-24 Francais Du Sang Ets Procede de production de progeniteurs erythroides
EP3650535A4 (en) 2017-07-07 2021-03-17 Kyoto University PROCESS AND APPARATUS FOR THE PRODUCTION OF PLATES AND METHOD FOR DETERMINING OPERATING CONDITIONS IN AN APPARATUS FOR THE PRODUCTION OF PLATES
WO2019059235A1 (ja) 2017-09-19 2019-03-28 株式会社メガカリオン 精製血小板の製造方法、血小板製剤の製造方法、血液製剤の製造方法、血小板保存液、血小板保存剤および血小板の保存方法
JP7160353B2 (ja) 2017-09-19 2022-10-25 株式会社メガカリオン 血小板の製造方法、血小板製剤の製造方法、および血液製剤の製造方法
MX2020007071A (es) 2018-01-05 2020-11-11 Platelet Biogenesis Inc Composiciones y metodos para producir megacariocitos.
WO2020006539A1 (en) 2018-06-29 2020-01-02 Platelet Biogenesis, Inc. Compositions for drug delivery and methods of use thereof
TW202045202A (zh) * 2019-02-25 2020-12-16 國立陽明大學 用於治療肺纖維化和肺氣腫的組合物及其使用方法
CA3138298A1 (en) * 2019-05-01 2020-11-05 Transfusion Health, Llc Methods of making oligopotent and unipotent precursors
WO2021117886A1 (ja) 2019-12-12 2021-06-17 国立大学法人千葉大学 巨核球および血小板を含む凍結乾燥製剤
WO2021117900A1 (ja) 2019-12-13 2021-06-17 株式会社メガカリオン 組成物およびその用途
CN116437940A (zh) 2020-10-27 2023-07-14 国立大学法人长崎大学 骨形成组合物和其用途
JP7716851B2 (ja) * 2020-12-28 2025-08-01 イビデン株式会社 凍結保存液
WO2022265117A1 (ja) 2021-06-18 2022-12-22 株式会社メガカリオン 血小板産生能が増強された多核化巨核球細胞の製造方法、血小板の製造方法、血小板製剤の製造方法、および血液製剤の製造方法
WO2023277153A1 (ja) 2021-06-30 2023-01-05 国立大学法人千葉大学 骨髄系共通前駆細胞（ｃｍｐ）又は骨髄球系前駆細胞の増殖性を向上させる方法
WO2024010317A1 (ko) * 2022-07-04 2024-01-11 주식회사 아트블러드 유전자 과발현 조합을 이용한 적혈구 분화능이 우수한 불멸화 적혈구전구세포주 확립, 이의 제조방법 및 용도
JP2025534107A (ja) 2022-10-18 2025-10-09 ソングァン メディカル ファンデーション 幹細胞から血小板前駆細胞への分化誘導用培地組成物及びそれを用いた分化方法
JPWO2024143555A1 (cg-RX-API-DMAC7.html) 2022-12-28 2024-07-04
JPWO2024210126A1 (cg-RX-API-DMAC7.html) 2023-04-03 2024-10-10

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004031373A1 (ja) * 2002-10-07 2004-04-15 National Institute Of Advanced Industrial Science And Technology 分化細胞の作製方法
CN101356270A (zh) * 2005-12-13 2009-01-28 国立大学法人京都大学 核重新编程因子
JP2009511081A (ja) * 2005-10-18 2009-03-19 ナショナル ジューイッシュ メディカル アンド リサーチ センター 条件的に不死化された長期幹細胞およびそのような細胞を作製および使用する方法
CN101492676A (zh) * 2008-09-16 2009-07-29 中国科学院广州生物医药与健康研究院 用脑膜细胞生成诱导的多能性干细胞的方法及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US572333A (en) 1896-12-01 Evaporating apparatus
JPH06508749A (ja) 1991-06-28 1994-10-06 ニュー　イングランド　ディーコネス　ホスピタル 新規な巨核球分化因子を産生する分化した巨核球の一系統
GB9502022D0 (en) * 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US5723333A (en) 1995-02-10 1998-03-03 Regents Of The University Of California Human pancreatic cell lines: developments and uses
WO1996024669A1 (en) 1995-02-10 1996-08-15 The Regents Of The University Of California Human pancreatic cell lines: developments and uses
US20050159378A1 (en) * 2001-05-18 2005-07-21 Sirna Therapeutics, Inc. RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)
WO2004029208A2 (en) * 2002-09-27 2004-04-08 Bioe, Inc. Cell separation compositions and methods
JP2004350601A (ja) 2003-05-29 2004-12-16 Tanabe Seiyaku Co Ltd 霊長類動物の胚性幹細胞から造血系細胞への分化方法
JP4706208B2 (ja) 2004-08-27 2011-06-22 株式会社アイル 造血幹細胞の製造方法
JP2006141356A (ja) 2004-11-24 2006-06-08 Institute Of Physical & Chemical Research Ｅｓ細胞から樹立された造血幹細胞
AU2006311637A1 (en) * 2005-11-07 2007-05-18 The General Hospital Corporation Methods and compositions for modulation of stem cell aging
US8058064B2 (en) 2006-10-04 2011-11-15 The University Of Tokyo Sac-like structure enclosing hematopoietic progenitor cells produced from ES cells and method for preparing blood cells
AU2008297024B2 (en) 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004031373A1 (ja) * 2002-10-07 2004-04-15 National Institute Of Advanced Industrial Science And Technology 分化細胞の作製方法
JP2009511081A (ja) * 2005-10-18 2009-03-19 ナショナル ジューイッシュ メディカル アンド リサーチ センター 条件的に不死化された長期幹細胞およびそのような細胞を作製および使用する方法
CN101356270A (zh) * 2005-12-13 2009-01-28 国立大学法人京都大学 核重新编程因子
CN101492676A (zh) * 2008-09-16 2009-07-29 中国科学院广州生物医药与健康研究院 用脑膜细胞生成诱导的多能性干细胞的方法及其用途

Also Published As

Publication number Publication date
US20160115449A1 (en) 2016-04-28
JP6382917B2 (ja) 2018-08-29
BR122013008030B8 (pt) 2021-07-27
CA2774193A1 (en) 2011-03-24
EP2500418A1 (en) 2012-09-19
RU2012114427A (ru) 2013-10-27
EP3159001B1 (en) 2019-03-06
US9200254B2 (en) 2015-12-01
JPWO2011034073A1 (ja) 2013-02-14
EP2500418A4 (en) 2013-04-10
DK2500418T3 (en) 2018-04-30
ES2725688T3 (es) 2019-09-26
BR122013008030A2 (pt) 2019-08-06
ES2664194T3 (es) 2018-04-18
EP2500418B1 (en) 2018-01-17
KR101834687B1 (ko) 2018-03-05
BR112012005710B1 (pt) 2020-06-09
CN105385659A (zh) 2016-03-09
WO2011034073A1 (ja) 2011-03-24
JP6265437B2 (ja) 2018-01-24
KR20160121592A (ko) 2016-10-19
CN102712906A (zh) 2012-10-03
BR122013008030B1 (pt) 2021-01-05
CA2774193C (en) 2020-08-25
RU2603094C2 (ru) 2016-11-20
AU2010296415B2 (en) 2014-07-03
US10087419B2 (en) 2018-10-02
CN105385659B (zh) 2019-06-28
KR101667834B1 (ko) 2016-10-20
EP3159001A1 (en) 2017-04-26
JP2015130866A (ja) 2015-07-23
IN2012DN02642A (cg-RX-API-DMAC7.html) 2015-09-11
BR112012005710A2 (pt) 2017-11-21
AU2010296415A1 (en) 2012-04-05
JP2017046719A (ja) 2017-03-09
JP2015213520A (ja) 2015-12-03
JP5791191B2 (ja) 2015-10-07
KR20120064109A (ko) 2012-06-18
US20120238023A1 (en) 2012-09-20
DK3159001T3 (da) 2019-06-17
RU2661107C1 (ru) 2018-07-11

Similar Documents

Publication Publication Date Title
CN102712906B (zh) 分化细胞的新型制备方法
CN103814126B (zh) 多核巨核细胞以及血小板的制造方法
AU2021361241A1 (en) Production of megakaryocytes and platelets in a co-culture system
AU2017202019B2 (en) Novel Method for Producing Differentiated Cells
HK1233181A (en) Novel method for producing differentiated cells
HK1233181A1 (en) Novel method for producing differentiated cells

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant